scholarly article | Q13442814 |
P50 | author | Chang-Qing Xia | Q60987124 |
Michael J Clare-Salzler | Q88347501 | ||
P2093 | author name string | Jeannette Lo | |
Ruihua Peng | |||
P2860 | cites work | Generation of antigen-specific Foxp3+ regulatory T-cells in vivo following administration of diabetes-reversing tolerogenic microspheres does not require provision of antigen in the formulation | Q41215778 |
Impaired SLAM-SLAM homotypic interaction between invariant NKT cells and dendritic cells affects differentiation of IL-4/IL-10-secreting NKT2 cells in nonobese diabetic mice. | Q41649585 | ||
Treatment of new-onset type 1 diabetes with peptide DiaPep277 is safe and associated with preserved beta-cell function: extension of a randomized, double-blind, phase II trial | Q42504585 | ||
Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells | Q42944333 | ||
Attenuation of inducible Th2 immunity with autoimmune disease progression | Q43497362 | ||
Regulatory Th2 response induced following adoptive transfer of dendritic cells in prediabetic NOD mice | Q44062613 | ||
1,25-Dihydroxyvitamin D3 alters the profile of bone marrow-derived dendritic cells of NOD mice | Q45256436 | ||
Re-establishing immune tolerance in type 1 diabetes via regulatory T cells. | Q45883089 | ||
Infectious Th1 and Th2 autoimmunity in diabetes‐prone mice | Q45983475 | ||
Homeostatic proliferation of naïve CD8+ T cells depends on CD62L/L-selectin-mediated homing to peripheral LN. | Q46156069 | ||
The frequency of high avidity T cells determines the hierarchy of determinant spreading | Q46180161 | ||
Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes-prone mice | Q46345979 | ||
Antigen-based therapies using ignored determinants of beta cell antigens can more effectively inhibit late-stage autoimmune disease in diabetes-prone mice | Q46419442 | ||
Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes | Q46512140 | ||
Antigen-based immunotherapy drives the precocious development of autoimmunity | Q46626418 | ||
GAD65 vaccination: 5 years of follow-up in a randomised dose-escalating study in adult-onset autoimmune diabetes | Q47912616 | ||
Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23) | Q33592891 | ||
Dendritic cells transduced to express interleukin 4 reduce diabetes onset in both normoglycemic and prediabetic nonobese diabetic mice | Q33649618 | ||
Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. | Q33977505 | ||
Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-gamma transcription | Q34201095 | ||
Dendritic cells as a tool to induce anergic and regulatory T cells | Q34295082 | ||
IL-7 is essential for homeostatic control of T cell metabolism in vivo | Q34307992 | ||
A short pulse of IL-4 delivered by DCs electroporated with modified mRNA can both prevent and treat autoimmune diabetes in NOD mice. | Q34382930 | ||
Effective expansion of alloantigen-specific Foxp3+ CD25+ CD4+ regulatory T cells by dendritic cells during the mixed leukocyte reaction | Q34479579 | ||
DEC-205 as a marker of dendritic cells with regulatory effects on CD8 T cell responses | Q34508459 | ||
Immature, but not inactive: the tolerogenic function of immature dendritic cells | Q34842360 | ||
Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients | Q35160185 | ||
Prevention of diabetes in nonobese diabetic mice by dendritic cell transfer | Q35821238 | ||
Recent advances in dendritic cell biology | Q36094388 | ||
Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes | Q36366434 | ||
Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells | Q36371345 | ||
CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. | Q36399104 | ||
Dendritic cells expand antigen-specific Foxp3+ CD25+ CD4+ regulatory T cells including suppressors of alloreactivity. | Q36563563 | ||
Type 1 diabetes patients have significantly lower frequency of plasmacytoid dendritic cells in the peripheral blood | Q37014824 | ||
The defect in T-cell regulation in NOD mice is an effect on the T-cell effectors | Q37018786 | ||
Complications of splenectomy | Q37154229 | ||
Lymphoid stroma in the initiation and control of immune responses. | Q37257010 | ||
Tolerogenic dendritic cell-regulatory T-cell interaction and the promotion of transplant tolerance | Q37353045 | ||
Therapy with GAD in diabetes | Q37408187 | ||
Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein. | Q37476298 | ||
Homeostatic proliferation and survival of naïve and memory T cells | Q37564251 | ||
Determinant spreading and the dynamics of the autoimmune T-cell repertoire. | Q40487702 | ||
Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo | Q40752701 | ||
BCG priming of dendritic cells enhances T regulatory and Th1 function and suppresses allergen-induced Th2 function in vitro and in vivo | Q52910803 | ||
Granulocyte-dendritic cell unbalance in the non-obese diabetic mice | Q52953838 | ||
Peptide-pulsed immature dendritic cells reduce response to beta cell target antigens and protect NOD recipients from type I diabetes | Q53586176 | ||
Qualitative and quantitative abnormalities in splenic dendritic cell populations in NOD mice | Q53905372 | ||
Defective maturation of myeloid dendritic cell (DC) in NOD mice is controlled by IDD10/17/18. | Q53908405 | ||
Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. | Q55066037 | ||
Dendritic Cells Transduced to Express Interleukin-4 Prevent Diabetes in Nonobese Diabetic Mice with Advanced Insulitis | Q62748513 | ||
Phenotypic and Functional Characteristics of BM-Derived DC from NOD and Non-Diabetes-Prone Strains | Q62748597 | ||
Immunization With the Larger Isoform of Mouse Glutamic Acid Decarboxylase (GAD67) Prevents Autoimmune Diabetes in NOD Mice | Q71656099 | ||
Peptide therapy for diabetes in NOD mice | Q72671513 | ||
Immunotherapy of NOD mice with bone marrow-derived dendritic cells | Q73224770 | ||
Major histocompatibility complex class I peptide-pulsed host dendritic cells induce antigen-specific acquired thymic tolerance to islet cells | Q73438405 | ||
A self MHC class II beta-chain peptide prevents diabetes in nonobese diabetic mice | Q73869271 | ||
Induction of tolerance by IL-10-treated dendritic cells | Q73873437 | ||
Induction of transplant tolerance with immunodominant allopeptide-pulsed host lymphoid and myeloid dendritic cells | Q74415746 | ||
The DPT-1 trial: a negative result with lessons for future type 1 diabetes prevention | Q74691160 | ||
Altered dendritic cells (DC) might be responsible for regulatory T cell imbalance and autoimmunity in nonobese diabetic (NOD) mice | Q77948340 | ||
Passive transfer of flt-3L-derived dendritic cells delays diabetes development in NOD mice and associates with early production of interleukin (IL)-4 and IL-10 in the spleen of recipient mice | Q79316172 | ||
Effect of oral insulin on insulin autoantibody levels in the Diabetes Prevention Trial Type 1 oral insulin study | Q80510733 | ||
Antisense oligonucleotides down-regulating costimulation confer diabetes-preventive properties to nonobese diabetic mouse dendritic cells | Q80597339 | ||
Dendritic cells support homeostatic expansion of Foxp3+ regulatory T cells in Foxp3.LuciDTR mice | Q82555014 | ||
Lowered expressions of the NF-kappaB family members in dendritic cells from NOD mice are associated with a reduced expression of GATA-2 | Q83140347 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P921 | main subject | dendritic cell | Q506253 |
P304 | page(s) | 5463879 | |
P577 | publication date | 2018-02-14 | |
P1433 | published in | Journal of Immunology Research | Q26841936 |
P1476 | title | Immature Dendritic Cell Therapy Confers Durable Immune Modulation in an Antigen-Dependent and Antigen-Independent Manner in Nonobese Diabetic Mice | |
P478 | volume | 2018 |
Q90190141 | Induction of Antitumor Immunity by Exosomes Isolated from Cryopreserved Cord Blood Monocyte-Derived Dendritic Cells |
Q64268733 | Optimal Tolerogenic Dendritic Cells in Type 1 Diabetes (T1D) Therapy: What Can We Learn From Non-obese Diabetic (NOD) Mouse Models? |
Q61798675 | Tolerogenic Dendritic Cells and T-Regulatory Cells at the Clinical Trials Crossroad for the Treatment of Autoimmune Disease; Emphasis on Type 1 Diabetes Therapy |